HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Compound heterozygosity for two genotypes of alpha-thalassemia-2: hematological, biosynthetic and DNA studies.

Abstract
Hemoglobin and DNA gene analyses were carried out in two Black Canadian families. In Family Q, both the parents and the brother were found to be heterozygotes for alpha-thalassemia-2 with the following alpha-genotypes: -alpha 3.7/alpha alpha, -alpha 4.2/alpha alpha and -alpha 4.2/alpha alpha, respectively. In Family C, the mother was found to be a homozygote for alpha-thalassemia-2 with the alpha-genotype of -alpha 3.7/-alpha 3.7. In both families, the propositi were compound heterozygotes for alpha-thalassemia-2 with the alpha-genotype of -alpha 3.7/-alpha 4.2. The propositus in Family C was also a sickle cell trait carrier. The usefulness of DNA gene analyses in family studies of hemoglobinopathy was discussed.
AuthorsS C Wong, L S Chang, N F Olivieri, A O Poon, M A Ali, D J Groves
JournalHemoglobin (Hemoglobin) Vol. 9 Issue 2 Pg. 111-26 ( 1985) ISSN: 0363-0269 [Print] England
PMID4030379 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobins
  • DNA
Topics
  • Adult
  • DNA (analysis)
  • Erythrocytes (pathology)
  • Genotype
  • Hemoglobins (analysis)
  • Heterozygote
  • Humans
  • Infant
  • Male
  • Pedigree
  • Thalassemia (blood, genetics, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: